| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study
|
Van Den Neste, Eric
|
|
2012
|
71 |
3 |
p. 581-591
|
artikel
|
| 2 |
A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker
|
Hirakawa, Masahiro
|
|
2013
|
71 |
3 |
p. 789-797
|
artikel
|
| 3 |
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies
|
Deeken, John F.
|
|
2012
|
71 |
3 |
p. 627-633
|
artikel
|
| 4 |
A randomized, double-blind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumors
|
Heath, Elisabeth I.
|
|
2013
|
71 |
3 |
p. 565-573
|
artikel
|
| 5 |
Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial
|
Njiaju, U. O.
|
|
2012
|
71 |
3 |
p. 613-618
|
artikel
|
| 6 |
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
|
Fine, Robert L.
|
|
2013
|
71 |
3 |
p. 663-670
|
artikel
|
| 7 |
Characterization of the long-term pharmacokinetics of bevacizumab following last dose in patients with resected stage II and III carcinoma of the colon
|
Li, Jing
|
|
2012
|
71 |
3 |
p. 575-580
|
artikel
|
| 8 |
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients
|
Ludovini, V.
|
|
2013
|
71 |
3 |
p. 671-680
|
artikel
|
| 9 |
Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group
|
Kentepozidis, N.
|
|
2013
|
71 |
3 |
p. 605-612
|
artikel
|
| 10 |
(−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α
|
He, Li
|
|
2013
|
71 |
3 |
p. 713-725
|
artikel
|
| 11 |
Erratum to: The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels
|
Opdam, F. L.
|
|
2013
|
71 |
3 |
p. 603
|
artikel
|
| 12 |
Immunogenicity and toxicity of transferrin receptor-targeted hybrid peptide as a potent anticancer agent
|
Kawamoto, Megumi
|
|
2013
|
71 |
3 |
p. 799-807
|
artikel
|
| 13 |
Immunohistochemical study of MRP5 expression in meningiomas
|
Alexiou, George A.
|
|
2012
|
71 |
3 |
p. 825-828
|
artikel
|
| 14 |
Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy
|
Phua, Lee Cheng
|
|
2012
|
71 |
3 |
p. 817-823
|
artikel
|
| 15 |
Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609
|
Taguchi, Tetsuya
|
|
2013
|
71 |
3 |
p. 741-747
|
artikel
|
| 16 |
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
|
Silverman, Jeffrey A.
|
|
2012
|
71 |
3 |
p. 555-564
|
artikel
|
| 17 |
Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix
|
Shoji, Tadahiro
|
|
2012
|
71 |
3 |
p. 657-662
|
artikel
|
| 18 |
Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine
|
Boyette-Davis, Jessica A.
|
|
2012
|
71 |
3 |
p. 619-626
|
artikel
|
| 19 |
Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites
|
Tamegai, Hidenori
|
|
2013
|
71 |
3 |
p. 727-731
|
artikel
|
| 20 |
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
|
Welsh, J. L.
|
|
2013
|
71 |
3 |
p. 765-775
|
artikel
|
| 21 |
Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumours
|
Delord, J. P.
|
|
2013
|
71 |
3 |
p. 647-656
|
artikel
|
| 22 |
Phase I/II study of amrubicin in combination with S-1 as second-line chemotherapy for non-small-cell lung cancer without EGFR mutation
|
Murakami, Shuji
|
|
2013
|
71 |
3 |
p. 705-711
|
artikel
|
| 23 |
p75NTR: an enhancer of fenretinide toxicity in neuroblastoma
|
Ganeshan, Veena
|
|
2013
|
71 |
3 |
p. 777-787
|
artikel
|
| 24 |
Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors
|
Ferron, Géraldine M.
|
|
2013
|
71 |
3 |
p. 681-692
|
artikel
|
| 25 |
Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years
|
Kontny, Nina E.
|
|
2013
|
71 |
3 |
p. 749-763
|
artikel
|
| 26 |
Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery
|
Pérez-Ruixo, Carlos
|
|
2012
|
71 |
3 |
p. 693-704
|
artikel
|
| 27 |
Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells
|
Morad, Samy A. F.
|
|
2012
|
71 |
3 |
p. 635-645
|
artikel
|
| 28 |
The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts
|
Forrest, Robert A.
|
|
2012
|
71 |
3 |
p. 809-816
|
artikel
|
| 29 |
The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels
|
Opdam, F. L.
|
|
2012
|
71 |
3 |
p. 593-601
|
artikel
|
| 30 |
XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis
|
Ye, Fanghui
|
|
2013
|
71 |
3 |
p. 733-740
|
artikel
|
Tijdschrift beschrijving